Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin Cancer Cell
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data JCO CLIN CANCER INFO
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study Blood Adv
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP) Front Pediatr
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials Clin Cancer Res
Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas Front Oncol
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors Cancer Res Commun
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study Blood Cancer J
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma Future Oncol
Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome Leukemia